It has been shown that targeting the EGFR/PCNA signalling suppresses tumour growth of triple-negative breast cancer cells [35] and inhibit cancer growth in neuroblastoma and breast cancer mouse xenograft models [36]. The gene discussed is EGFR; the disease is cancer.